A digital medical AI project was recently introduced to the Guiyang National High-tech Industrial Development Zone (Guiyang HIDZ) in Guiyang, capital of Southwest China's Guizhou province.
The project will be managed by DianNei (Shanghai) Biotechnology Co, which has registered and is conducting business in the zone.
According to the plan, DianNei Technology will establish its Guizhou headquarters in the Guiyang HIDZ, bringing in top domestic medical and AI industry experts and empowering the digitalization of Guizhou's medical industry.
This will promote the standardization and securitization of Guizhou's medical and health data and replicate it throughout the whole country.
It has been reported that DianNei Technology is an "expertise-oriented" enterprise focusing on tumors.
The company cooperates with top domestic departments and relies on a strong team of AI experts to use expert clinical data and medical image data as production factors.
As such, DianNei Technology has built an AI-assisted diagnosis model for hospitals and provides lung cancer prevention programs and related medical, health, and financial products for patients, maximizing the commercial value of medical big data.
This successful partnership is the result of this year's China International Big Data Industry Expo. According to a spokesperson from the investment promotion bureau of the Guiyang HIDZ, it took just one month from the start of negotiations to land the project.